SurroMed and PPD sign strategic collaboration
PPD Will Increase Investment in SurroMed and Commit to Biomarker Discovery Effort
07-Aug-2003 -
SurroMed, Inc. today announced it has entered into a strategic collaboration with PPD, Inc. that involves a cash investment and a sale of assets, including a range of cancer biomarkers, by PPD to SurroMed in return for a total of $24 million of a new series of SurroMed senior preferred stock. In ...
biomarker
biomarkers
cancer biomarkers
+4